These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8176943)

  • 1. Lipiodolization for unresectable hepatocellular carcinoma: an analysis of 205 patients using univariate and multivariate analysis.
    Urata K; Matsumata T; Kamakura T; Hasuo K; Sugimachi K
    J Surg Oncol; 1994 May; 56(1):54-8. PubMed ID: 8176943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Eight cases of non-resectable hepatocellular carcinoma surviving for more than 3 years after Lipiodol administration].
    Shirabe K; Kanematsu T; Utsunomiya T; Furuta T; Yamagata M; Matsumata T; Sugimachi K; Yasumori K; Masuda K
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2974-7. PubMed ID: 2551238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M
    Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Lladó L; Virgili J; Figueras J; Valls C; Dominguez J; Rafecas A; Torras J; Fabregat J; Guardiola J; Jaurrieta E
    Cancer; 2000 Jan; 88(1):50-7. PubMed ID: 10618605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipiodol drug targeting in the treatment of primary hepatocellular carcinoma.
    Kanematsu T; Matsumata T; Furuta T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):442-4. PubMed ID: 2174820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipiodolization prolongs survival rates in postoperative patients with a recurrent hepatocellular carcinoma.
    Furuta T; Kanematsu T; Matsumata T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):494-7. PubMed ID: 2174829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma.
    Lu CD; Qi YG; Peng SY
    Chin Med J (Engl); 1994 Mar; 107(3):209-15. PubMed ID: 8088182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Takaki S; Katamura Y; Hiramatsu A; Waki K; Takahashi S; Hieda M; Toyota N; Ito K; Chayama K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):687-94. PubMed ID: 19444503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
    Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
    J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unresectable fibrolamellar hepatocellular carcinoma treated with intra-arterial lipiodolised doxorubicin. A case report.
    Spence RA; Rosen A; Krige JE; Blumgart RL; Temple-Camp CR; Terblanche J
    S Afr Med J; 1987 Nov; 72(10):701-3. PubMed ID: 2825364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arteriopathy after transarterial chemo-lipiodolization for hepatocellular carcinoma.
    Matsui Y; Figi A; Horikawa M; Jahangiri Noudeh Y; Tomozawa Y; Hashimoto K; Kaufman JA; Farsad K
    Diagn Interv Imaging; 2017 Dec; 98(12):827-835. PubMed ID: 29157897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
    O'Suilleabhain CB; Poon RT; Yong JL; Ooi GC; Tso WK; Fan ST
    Br J Surg; 2003 Mar; 90(3):325-31. PubMed ID: 12594668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors.
    Uraki J; Yamakado K; Nakatsuka A; Takeda K
    Eur J Radiol; 2004 Jul; 51(1):12-8. PubMed ID: 15186879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients.
    Dumortier J; Chapuis F; Borson O; Davril B; Scoazec JY; Poncet G; Henry L; Boillot O; Mion F; Berger F; Partensky C; Paliard P; Valette PJ
    Dig Liver Dis; 2006 Feb; 38(2):125-33. PubMed ID: 16389002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma.
    Kanematsu T; Furuta T; Takenaka K; Matsumata T; Yoshida Y; Nishizaki T; Hasuo K; Sugimachi K
    Hepatology; 1989 Jul; 10(1):98-102. PubMed ID: 2544499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intra-arterial injection of cisplatin suspension in lipiodol (LPS) for the treatment of advanced hepatocellular carcinoma (stage IV)].
    Shibata J; Kimura S; Nakashima M; Nakazono K; Miyase S; Sakai M; Fujiyama S; Sato T
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):357-64. PubMed ID: 2539053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case report of hepatocellular carcinoma with portal thrombus responding to hepatic arterial infusion chemo-lipiodolization].
    Masutani S; Shimizu J; Tatsuta M; Katoh H; Kitani K; Esumi K; Masuda N; Imamura H; Ishida H; Furukawa H; Onishi H; Tsuda K; Inoue Y; Tomotsu K; Usui T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2378-81. PubMed ID: 12484079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter arterial embolization for advanced hepatocellular carcinoma resulting in a curative resection: report of two cases.
    Mizoe A; Yamaguchi J; Azuma T; Fujioka H; Furui J; Kanematsu T
    Hepatogastroenterology; 2000; 47(36):1706-10. PubMed ID: 11149037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.